Jason Coloma
CEO of Maize
Replay available
Maze Therapeutics, Inc. (MAZE) Q4 2025 Earnings Call
Maze Therapeutics, Inc. (NASDAQ: MAZE) Q4 2025 earnings conference call, held 2026-03-25. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Harold Bernstein
President of R&D and Chief Medical Officer
Anupam Rama
Analyst, JP Morgan
Debjit Chattopadhyay
Analyst, Guggenheim Securities
Joseph Schwartz
Analyst, Learing Partners
Tyler Van Buren
Analyst, TD Cowen
Selim Saeed
Analyst, Mizuho
Laura Chico
Analyst, Wedbush Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Maze Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.618 Good day and welcome to the May Therapeutics Horizon MZE829 00:00:04.618 -- 00:00:09.345 Top Line Data conference call. All participants will be in a listen-only mode. 00:00:09.345 -- 00:00:12.970 Should you need assistance, please signal conference specialists by pressing the star 00:00:12.970 -- 00:00:17.717 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:17.717 -- 00:00:22.764 questions. To ask a question, you may press star then one on your touchtone phone. 00:00:22.764 -- 00:00:26.189 And to withdraw your question, please press star then two. 00:00:26.189 -- 00:00:29.714 Please note this event is being recorded. I would now like to turn the conference over 00:00:29.714 -- 00:00:33.897 to Ms. Amy Backworld. Please go ahead. 00:00:34.520 -- 00:00:37.303 Good morning, all, and thank you for joining us. 00:00:37.303 -- 00:00:41.869 Today, we will be discussing this morning's announcement of positive tap line data from 00:00:41.869 -- 00:00:46.154 the Phase II Horizon Trial of MZE829, 00:00:46.154 -- 00:00:51.621 an oral small molecule dual mechanism APOL1 inhibitor for the treatment of broad 00:00:51.621 -- 00:00:55.906 APOL1-mediated kidney disease, or AMKD. 00:00:55.906 -- 00:00:59.488 Please note this conference call is being recorded. 00:01:00.443 -- 00:01:04.306 Before we start, I would like to remind you that today's conference call will include 00:01:04.306 -- 00:01:09.271 forward-looking statements. Such statements represent management's judgment and intention 00:01:09.271 -- 00:01:13.715 as of today and involve assumptions, risks, and uncertainties. 00:01:13.715 -- 00:01:18.719 MAIS undertakes no obligation to update or revise any forward-looking statements. 00:01:18.719 -- 00:0...